publication date: Sep. 25, 2020

Funding Opportunities

Thermo Fisher Scientific to grant up to $200,000 for oncomine clinical research

Thermo Fisher Scientific has introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health.

The program aims to provide support for high-quality molecular profiling studies focused on the generation of data that may improve clinical outcomes for patients in the future.

As part of an initial pilot focused on oncology, the company is calling for proposals dedicated to gene fusions in solid tumors and molecular testing in blood cancers. Grant proposals are now being accepted through Oct. 31, 2020.

Through the program, Thermo Fisher will award selected independent clinical research teams with financial support. The applications will be reviewed based on scientific merit by a panel of external experts and members of the Thermo Fisher Medical Affairs team.

Each proposal has the opportunity to receive an award worth up to $200,000 in reagents and funding, along with the opportunity to work with the Ion Torrent Genexus Systems for the duration of their project. The Genexus System is the first next-generation sequencing platform featuring an automated specimen-to-report workflow that delivers results economically in a single day.

The program will provide grantees access to Thermo Fisher’s NGS system, which has been designed to accelerate molecular profiling and generate data through an automated workflow.

 

Foundation for Giving Life to grant four young scientists up to $270,000 for blood cancer research

The DKMS Stiftung Leben Spenden (Foundation for Giving Life) plans to support up to four international young scientists each year who want to advance the fight against blood cancer … Continue reading Thermo Fisher Scientific to grant up to $200,000 for oncomine clinical research

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.